£108.91

Springer - Novel Immunotherapeutic Approaches to Cancer Treatment

Price data last checked 16 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£109 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 75 days · 75 data points (no recent data)

Historical
Generating forecast…
£108.91 £103.46 £105.64 £107.82 £110.00 £112.18 £114.36 03 May 2026 21 May 2026 09 June 2026 27 June 2026 16 July 2026

Price Distribution

Price distribution over 75 days • 1 price levels

Days at Price
75 days 0 19 38 56 75 £109 Days at Price

Price Analysis

Most common price: £109 (75 days, 100.0%)

Price range: £109 - £109

Price levels: 1 different prices over 75 days

Description

Explore the radical transformation in cancer care with this comprehensive guide on novel technologies and personalized medicine. As the field shifts toward treatments that augment the immune response to tumors, understanding the latest breakthroughs is essential for medical professionals. This text examines the most advanced developments in immune therapeutics, focusing on how these methods target tumor cells. It provides in-depth coverage of immune checkpoint inhibitors, which represent some of the most significant advancements in the industry. You will learn about approved antibody drugs directed at cell surface proteins such as CTLA4 and PD-1. These therapies are now considered foundational treatments for several solid tumor indications. This book serves as a vital resource for those studying the drug development and clinical application of modern immunotherapy. Stay informed on the technologies driving the future of oncology and the evolution of cancer treatment strategies.

Key Features

Covers the shift toward personalized medicine and new technologies in cancer care.

Provides detailed information on therapeutics that augment the immune response to tumors.

Analyzes immune checkpoint inhibitors as highly advanced examples of immune therapeutics.

Explains the application of approved antibody drugs targeting CTLA4 and PD-1 proteins.

Examines the role of foundational treatments for various solid tumor indications.

Focuses on the drug development process and clinical application of modern immunotherapy.

Product Specifications

Barcode

No barcode data available